LIDOCAINE HCI AND DEXTROSE

Product NDC
51662-1565
11-digit product format
516621565
Labeler code
51662
Product ID
51662-1565_c75311e3-ca6f-40de-e053-2a95a90a1bda
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
LIDOCAINE HCI AND DEXTROSE
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Application
NDA019830
Marketing category
NDA
Marketing start
2021-07-17
Substance
DEXTROSE MONOHYDRATE; LIDOCAINE HYDROCHLORIDE ANHYDROUS
Active strength
5; .8 g/100mL; g/100mL
Pharmacologic classes
Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
LIDOCAINE HCI AND DEXTROSE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DEXTROSE MONOHYDRATE5 g/100mL
LIDOCAINE HYDROCHLORIDE ANHYDROUS.8 g/100mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiLX22YL083G, EC2CNF7XFP
Rxcui1737723

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
860a93dc-4863-49cc-b284-6bbe8191bc48Product name420250214
eaba870a-6a9d-442e-8643-87b3f558a451Product name120250117
cb89b86a-369e-4204-8910-ae797c503af3Product name120230706
9b4cf230-fd05-41d5-98c6-5db9ecb27b86Product name120230117
d4880ace-a516-8c47-8dfd-73a4ba5887d7Product name220180830
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
fa8b5901-e681-426f-82fe-54f6d81ec698Product name420180619
332d03e4-aa24-4b11-841a-02bf41081920Product name120171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070Product name120171221
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
68ed98f8-24c2-44a0-944a-6d36e82ce25aProduct name120141222
1cd42bc2-a430-c72b-636d-991b235fbf80Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51662-1565-1LIDOCAINE HCI AND DEXTROSE250 mL in 1 CONTAINERINJECTION, SOLUTION2501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51662-1565LIDOCAINE HCI AND DEXTROSE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]1Current NDC, Legacy NDC, 1 package rows20210719_c75311e3-ca6e-40de-e053-2a95a90a1bda.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1737723lidocaine HCl 0.8 % in 250 ML InjectionPSNc75311e3-ca6e-40de-e053-2a95a90a1bda1
1737723250 ML lidocaine hydrochloride 8 MG/ML InjectionSCDc75311e3-ca6e-40de-e053-2a95a90a1bda1
1737723lidocaine HCl 0.8 % per 250 ML InjectionSYc75311e3-ca6e-40de-e053-2a95a90a1bda1
1737723lidocaine HCl 2 GM per 250 ML InjectionSYc75311e3-ca6e-40de-e053-2a95a90a1bda1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51662-1565-151662156501250 mL in 1 CONTAINER (51662-1565-1) 250 ml2021-07-170000-00-00NoNoCurrent